Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, The Netherlands.
Spaarne Gasthuis Academy, Spaarne Gasthuis, Hoofddorp, The Netherlands.
Microbiol Spectr. 2023 Jun 15;11(3):e0405722. doi: 10.1128/spectrum.04057-22. Epub 2023 May 18.
16S-based sequencing provides broader information on the respiratory microbial community than conventional culturing. However, it (often) lacks species- and strain-level information. To overcome this issue, we used 16S rRNA-based sequencing results from 246 nasopharyngeal samples obtained from 20 infants with cystic fibrosis (CF) and 43 healthy infants, which were all 0 to 6 months old, and compared them to both standard (blind) diagnostic culturing and a 16S-sequencing-informed "targeted" reculturing approach. Using routine culturing, we almost uniquely detected Moraxella catarrhalis, Staphylococcus aureus, and Haemophilus influenzae (42%, 38%, and 33% of samples, respectively). Using the targeted reculturing approach, we were able to reculture 47% of the top-5 operational taxonomical units (OTUs) in the sequencing profiles. In total, we identified 60 species from 30 genera with a median of 3 species per sample (range, 1 to 8). We also identified up to 10 species per identified genus. The success of reculturing the top-5 genera present from the sequencing profile depended on the genus. In the case of being in the top 5, we recultured them in 79% of samples, whereas for Staphylococcus, this value was only 25%. The success of reculturing was also correlated with the relative abundance of those genera in the corresponding sequencing profile. In conclusion, revisiting samples using 16S-based sequencing profiles to guide a targeted culturing approach led to the detection of more potential pathogens per sample than conventional culturing and may therefore be useful in the identification and, consequently, treatment of bacteria considered relevant for the deterioration or exacerbation of disease in patients like those with CF. Early and effective treatment of pulmonary infections in cystic fibrosis is vital to prevent chronic lung damage. Although microbial diagnostics and treatment decisions are still based on conventional culture methods, research is gradually focusing more on microbiome and metagenomic-based approaches. This study compared the results of both methods and proposed a way to combine the best of both worlds. Many species can relatively easily be recultured based on the 16S-based sequencing profile, and it provides more in-depth information about the microbial composition of a sample than that obtained through routine (blind) diagnostic culturing. Still, well-known pathogens can be missed by both routine diagnostic culture methods as well as by targeted reculture methods, sometimes even when they are highly abundant, which may be a consequence of either sample storage conditions or antibiotic treatment at the time of sampling.
16S 测序比传统培养提供了更广泛的呼吸微生物群落信息。然而,它(通常)缺乏物种和菌株水平的信息。为了克服这个问题,我们使用了 246 份来自 20 名囊性纤维化(CF)婴儿和 43 名健康婴儿的鼻咽样本的 16S rRNA 测序结果,这些婴儿均为 0 至 6 个月大,并将其与标准(盲法)诊断培养和基于 16S 测序的“靶向”重培养方法进行了比较。使用常规培养,我们几乎可以单独检测到卡他莫拉菌、金黄色葡萄球菌和流感嗜血杆菌(分别为 42%、38%和 33%的样本)。使用靶向重培养方法,我们能够重培养测序图谱中前 5 位操作分类单元(OTUs)的 47%。总共从 30 个属中鉴定出 60 个种,每个样本的中位数为 3 个种(范围为 1 到 8)。我们还在每个鉴定属中鉴定出多达 10 个种。根据属的不同,从测序图谱中重培养前 5 位存在的属的成功率也不同。在属于前 5 位的情况下,我们在 79%的样本中重培养了它们,而对于金黄色葡萄球菌,这一比例仅为 25%。重培养的成功率也与相应测序图谱中这些属的相对丰度相关。总之,使用基于 16S 的测序图谱重新检查样本以指导靶向培养方法可以比传统培养检测到更多的潜在病原体,因此可能有助于识别和,因此,对于囊性纤维化等患者疾病恶化或恶化相关的细菌进行治疗。早期和有效的囊性纤维化肺部感染治疗对于预防慢性肺损伤至关重要。尽管微生物诊断和治疗决策仍然基于传统的培养方法,但研究正逐渐更多地关注微生物组和宏基因组方法。本研究比较了这两种方法的结果,并提出了一种结合两者优势的方法。许多物种可以根据 16S 测序图谱相对容易地进行再培养,并且它提供了比常规(盲法)诊断培养更深入的样本微生物组成信息。尽管如此,常规诊断培养方法和靶向重培养方法都可能会错过一些知名病原体,有时即使它们高度丰富,这可能是样本储存条件或采样时抗生素治疗的结果。